Results of the Campaign Dedicated to World Hepatitis Day

Results of the Campaign Dedicated to World Hepatitis Day

Introduction. The main measure to combat hepatitis C in the framework of its elimination plan is the “test and treat strategy”, as well as dissemination of knowledge on hepatitis C virus (HCV) infection among population. In order to raise awareness and increase the coverage with viral hepatitis test...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. V. Klushkina, Z. S. Rodionova, T. V. Tyrgina, E. V. Tivanova, I. V. Solovieva, V. V. Orlov, L. V. Telminova, E. B. Lapteva, R. S. Amirov, V. S. Kichatova, F. A. Asadi Mobarhan, A. A. Karlsen, O. V. Isaeva, A. N. Gerasimov, S. N. Kuzin, K. K. Kyuregyan, M. I. Mikhailov, V. G. Akimkin
Format:	Article
Language:	Russian
Published:	Numikom LLC 2025-07-01
Series:	Эпидемиология и вакцинопрофилактика
Subjects:	hepatitis c hepatitis c virus screening who elimination plan reflex testing
Online Access:	https://www.epidemvac.ru/jour/article/view/2256
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Drug resistant variants of hepatitis C virus genotype 1b in Russia: analysis of aminoacid substitutions in NS5a and core proteins
by: V. S. Kichatova, et al.
Published: (2018-12-01)

The prevalence of the hepatitis C virus among the conditionally healthy population of the Russian Federation
by: N. V. Soboleva, et al.
Published: (2017-06-01)

Dynamic changes in the prevalence of markers of hepatitis C virus infection among the conditionally healthy population of the Tyva Republic
by: A. A. Saryglar, et al.
Published: (2024-01-01)

Liver cirrhosis as a result of chronic hepatitis C
by: A. A. Sukhoruk, et al.
Published: (2014-09-01)

Clinical and epidemiological characteristic of chronic hepatitis C in the republic of Tyva
by: A. A. Saryglar, et al.
Published: (2023-04-01)

Characteristics of Hepatitis C Epidemic Process in the Republic of Belarus
by: V. S. Vysotskaya, et al.
Published: (2021-01-01)

Detection rate of specific antibodies to the HCV CORE+1 protein in “naive” cronically HCV-infected patients in depends on the stage of liver fibrosis and the HCV subtype
by: E. V. Lichnaya, et al.
Published: (2021-01-01)

PREVALENCE OF MARKERS OF VIRAL HEPATITIS B AND D FROM HEALTHY POPULATION IN REPUBLIC TYVA
by: T. V. Kozhanova, et al.
Published: (2015-08-01)

Clinical and epidemiological characteristics of D hepatitis В and delta in the Republic of Dagestan
by: S. A. Magomedova, et al.
Published: (2023-10-01)

Cycloferon Therapy of Acute and Chronic Virus Hepatitis C
by: V. P. Malyy, et al.
Published: (2020-05-01)

Tuberculosis and parenteral viral hepatitides: incidence of mixed forms
by: A. A. Asratyan, et al.
Published: (2014-11-01)

Hepatitis C screening and referral for further investigation and treatment in a tertiary care hospital
by: Gülşen İskender, et al.
Published: (2020-06-01)

Morphogenesis of pericellular liver fibrosis in patients with chronic viral hepatitis C associated with hepatic steatosis
by: V. A. Tumanskiy, et al.
Published: (2012-08-01)

RESULTS OF THE USE OF SOFOSBUVIR IN COMBINATION WITH LEDIPASVIR OR DACLATASVIR FOR CHRONIC HEPATITIS C TREATMENT IN THE REPUBLIC OF BELARUS
by: S. V. Zhavoronok, et al.
Published: (2018-10-01)

Retrospective Analysis of Experimental and Clinical Studies of Flakozid in Viral Hepatitis
by: V. V. Karabaeva, et al.
Published: (2021-11-01)

Seronegative fibrosing cholestatic hepatitis С after liver retransplantation for unresectable neuroendocrine tumor liver metastases
by: S. E. Voskanyan, et al.
Published: (2020-12-01)

Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
by: K. I. Yesmembetov, et al.
Published: (2013-07-01)

Cryoglobulinemia and hepatitis C virus
by: N. V. Dunaeva, et al.
Published: (2014-09-01)

State and prospects of therapeutic treatment of children with chronic hepatitis C in the Russian Federation
by: A. A. Fomicheva, et al.
Published: (2021-03-01)

Kinetics of Virus Load HCV-RNA in Blood Serum and Peripheral Mononuclear Cells in a Patient with Hepatocirrhosis and Chronic Virus Hepatitis C Termination Treated According to Noninterferon Treatment Scheme (Cycloferon + Ribavirin)
by: V. C. Stelmah, et al.
Published: (2020-05-01)

The interaction of morphological changes in the liver with the development of extrahepatic manifestations in patients with chronic hepatitis C
by: Yu. Yu. Riabokon, et al.
Published: (2018-04-01)

Сontent of interferon-γ and interleukin-4 in blood serum of patients with chronic hepatitis С with mixed crioglobulinemia
by: O. P. Mashko, et al.
Published: (2012-04-01)

Clinical and pathogenetic value of immune disruptions in manifestation of mixed cryoglobulinemia in patients with chronic hepatitis C
by: O. O. Furyk, et al.
Published: (2018-04-01)

VIRAL HEPATITIS B AND C AS COMORBIDITY IN RHEUMATIC DISEASES: ANALYSIS OF THE DATA OF THE V.A. NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY CLINIC OVER 4 YEARS
by: A. E. Karateev, et al.
Published: (2016-07-01)

Diffuse large B-cells lymphoma clinical features in patients with hepatitis B and C infection
by: G. I. Storozhakov, et al.
Published: (2022-11-01)

CXCR3 CHEMOKINE RECEPTOR EXPRESSION ON PERIPHERAL BLOOD B-CELL SUBSETS IN PATIENTS WITH CHRONIC HEPATITIS C
by: N. A. Arsentieva, et al.
Published: (2014-07-01)

Clinical and Epidemiological Characteristics of Hepatocellular Carcinoma in the Republic of Saha (Yakutia)
by: S. S. Sleptsova, et al.
Published: (2020-07-01)

INCIDENCE OF AUTOANTIBODIES IN PATIENTS WITH AUTOIMMUNE LIVER DISEASES AND CHRONIC HEPATITIS C
by: K. L. Raikhelson, et al.
Published: (2014-07-01)

The use of sofosbuvir for the treatment of recurrent hepatitis C after liver transplantation
by: M. Sh. Khubutiya, et al.
Published: (2017-03-01)

Clinical and laboratory characteristics of chronic hepatitis C on the early stages of development
by: N. S. Zhevnerova, et al.
Published: (2016-12-01)

The impact of the infection caused by hepatitis B and C on the characteristics of hepatotoxic reactions in tuberculosis patients
by: V. V. Dantsev, et al.
Published: (2020-08-01)

APOPTOSIS SYSTEM AND ITS RELATIONS TO HEPATOCELLULAR DAMAGE AND SOME INDEXES OF LOCAL CYTOKINE PROFILE CHRONIC HCV INFECTION
by: L. Ph. Skljar, et al.
Published: (2014-07-01)

Genotypic Diversity of Hepatitis C Virus in Tuberculosis Patients in the Tomsk Region
by: K. A. Svirin, et al.
Published: (2025-03-01)

Chronic viral hepatitis B and C in patients with tuberculosis: the proportion of nozoform, dynamic changes
by: S. V. Baramzina
Published: (2015-07-01)

Efficiency of Antiviral Therapy for Recurrence of Chronic Hepatitis C in Patients Undergoing Liver Transplantation
by: A. A. Sukhoruk, et al.
Published: (2014-09-01)

Association of CYP2E1*6 polymorphism of gene CYP2E1 with the risk and severity of chronic hepatitis C
by: V. V. Godovan, et al.
Published: (2014-06-01)

Self-testing strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of disease burden and cost-effectiveness
by: Gyeongseon Shin, et al.
Published: (2025-01-01)

Toxoplasmosis and liver disease: literature review and clinical observation
by: V. A. Greshnyakova, et al.
Published: (2021-07-01)

CHRONIC HEPATITIS B AND C IN WOMEN: COURSE OF PREGNANCY, DELIVERY AND MORPHOLOGICAL CHARACTERISTICS OF THE PLACENTA
by: M. A. Belopolskaya, et al.
Published: (2018-02-01)

Changes in Hepatitis C Virus Genotype Distribution in Diyarbakır from 2011 to 2020: The Impact of Migration and Epidemiological Trends
by: Esra Yenihal, et al.
Published: (2024-12-01)